Monitoring of the Safety and the Performance of the Endoscopic Cap Electrode (ECE50)
Launched by MED-EL ELEKTROMEDIZINISCHE GERÄTE GESMBH · Feb 17, 2022
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the safety and effectiveness of a device called the Endoscopic Cap Electrode (ECE50) for treating conditions related to vocal fold problems, specifically vocal fold paresis and laryngeal dystonia. The goal is to gather information on how well this device works in real-life medical settings. The trial is currently recruiting participants, and anyone between the ages of 18 and 74 who has a diagnosed issue with the muscles in their throat may be eligible to join.
To participate, individuals must be adults who can provide informed consent, meaning they understand the study and agree to take part. However, some people may not qualify, such as those with certain medical implants, known allergies to the materials used, or those already involved in another similar study. If eligible, participants can expect to contribute to valuable research that could help improve treatments for vocal fold disorders while being monitored for their safety throughout the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Legal adults (i.e., as a general rule patients ≥ 18 years old)
- • Legal adults requiring a diagnosis for a disorder that could be traced back to uni- or bilateral dysfunction of one or more laryngeal muscle(s) of the posterior cricoid region
- • Signed and dated informed consent before the start of any registry-specific procedure for all the recruited subjects
- Exclusion Criteria:
- • Lack of compliance with any inclusion criteria
- • Use of an active medical implant
- • Known allergies or intolerance to the material used for this registry
- • Parallel participation in a device/drug registry in the period of data collection, which could confound the results of the registry
- • Anything that, in the opinion of the Registry Responsible, would place the subject at increased risk or preclude the subject's full compliance with the general requirements of this registry
About Med El Elektromedizinische Geräte Gesmbh
MED-EL Elektromedizinische Geräte GmbH is a leading innovator in the field of medical technology, specializing in advanced hearing solutions. Established in 1989, the company focuses on developing implantable hearing devices and comprehensive rehabilitation solutions aimed at improving the quality of life for individuals with hearing loss. With a commitment to research and development, MED-EL collaborates with healthcare professionals and academic institutions to drive clinical trials that enhance auditory care and foster groundbreaking advancements in hearing healthcare. Their dedication to innovation and excellence positions MED-EL as a pivotal player in the global medical device industry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Berit Schneider-Stickler, Prof.Dr.med.
Principal Investigator
Univ. Klinik für Hals-, Nasen- und Ohrenkrankheiten, Vienna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials